Treatment of Congenital Generalized Lymphangiectasia With Propranolol in a Preterm Infant
Generalized lymphangiectasia is a rare congenital disorder characterized by dilated lymphatic vessels with a fatal prognosis, especially in cases with thoracic involvement. We describe the use of propranolol in the therapy of generalized lymphangiectasia in a preterm infant with hydrops fetalis. Propranolol was well tolerated and effective within the first months. It remains to be shown whether propranolol is a treatment option for infants with generalized lymphangiectasia.
- VEGF —
- vascular endothelial growth factor
- VEGFR-3 —
- vascular endothelial growth factor receptor 3
- Accepted July 11, 2013.
- Copyright © 2014 by the American Academy of Pediatrics